Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk
Rheumatic Disease Clinics of North America · 2023-02 · 49 (1) · 179-191
DOI: 10.1016/j.rdc.2022.08.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rheumatic Disease Clinics of North America, 2023-02. Verfasst von Deeba Minhas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, University of Michigan, 300 North Ingalls Building, Ann Arbor, MI 48109-5422, USA. Electro…. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Cardiovascular Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Rheumatology, University of Michigan, 300 North Ingalls Building, Ann Arbor, MI 48109-5422, USA. Electronic address: minhasde@med.umich.edu.
- Cleveland Clinic, Cleveland, 9500 Euclid Ave, Cleveland, Ohio 44195, USA.
Zitieren
APA
Minhas, D., Nidhaan, A., & Husni, M. E. (2023). Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk. Rheumatic Disease Clinics of North America, 49(1), 179-191. https://doi.org/10.1016/j.rdc.2022.08.006
Vancouver
Minhas D, Nidhaan A, Husni ME. Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk. Rheumatic Disease Clinics of North America. 2023;49(1):179-191. doi:10.1016/j.rdc.2022.08.006
BibTeX
@article{Minhas2023,
author = {Minhas, Deeba and Nidhaan, Anjali and Husni, M Elaine},
title = {Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk},
journal = {Rheumatic Disease Clinics of North America},
year = {2023},
volume = {49},
number = {1},
pages = {179--191},
doi = {10.1016/j.rdc.2022.08.006}
}
EUVIMED